Despite the initial high cost, the firm believes the assay's improved accuracy and sensitivity will sway clinical and payor interest.
Researchers identified rises and declines in disease risk that appeared to coincide with the proportion of ancestry from Mapuche and Aymara populations.
A genome-wide association study and meta-analysis uncovered several possible ties to multiple keratinocyte cancer versus single keratinocyte cancer cases.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.
The study confirmed 17 previously identified loci, and uncovered 14 new ones that researchers hope can improve understanding of BCC pathogenesis and inform strategies for prevention.
An international team has uncovered roles for MYCN, PTPN14, and LATS1 mutations in the development and progression of skin basal cell carcinoma.
An analysis of angiosarcoma-derived cell lines identified a NUP160-SLC43A3 fusion that subsequently turned up in aggressive primary tumor samples.
The startup firm makes a device as an alternative to skin biopsy that can inform PCR- or NGS-based molecular profiling of the sampled region.
The report cited cost and a lack of awareness of such testing among doctors as the main obstacles to greater adoption of MDx testing for cancer patients.
Researchers from the Sanger Institute used genomic sequencing to study how somatic mutations build up prior to becoming cancerous.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.